ZYBERNO
Stock Report
Updated Jun 8, 2026

ENCISION, INC. (ECIA)

Healthcare • Over The Counter

$0.00

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
10.0/100
POOR BUSINESS
ENCISION, INC. (ECIA) scores 10/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-22.3%)
Debt-to-Equity (Solvency Risk):AVERAGE (0.88x)
Operating Margin (Operational Efficiency):CRITICAL (-5.1%)
Return on Capital (Capital Efficiency):CRITICAL (-7.7%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

ENCISION, INC. (ECIA) stock report — Zyberno Score 10/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, ECIA generated -$339.97K in Owner Earnings. Capital was deployed as follows: $46.81K invested in capital expenditures.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.00
Market Cap:$4.26K

Valuation Multiples (3)

P/B Ratio:0.00x
P/S Ratio:0.00x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$1.23M
B. Profitability Assessment

Margin Analysis (3)

Operating Margin Ttm:-5.1%
Net Margin Ttm:-6.0%
Ebitda Margin:-3.7%

TTM Performance (3)

Gross Margin Ttm:52.6%
Operating Margin Ttm:-5.1%
Net Margin Ttm:-6.0%

Yield Metrics (2)

Earnings Yield:-$10.00K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-60.0%
Latest Earnings Filed:2025-11-13

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-6.6%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):-18.9%
Operating Cash Flow Growth Rate (Linear):-17.5%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:2.28x
Quick Ratio:0.91x
Cash Ratio:0.07x

Leverage Analysis (3)

Debt To Equity Ttm:0.88x
Debt-to-Equity Ratio:0.88x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-3.06x
Times Interest Earned:-3.06

Capital Structure (4)

Working Capital:1,375,301.00
Cash And Cash Equivalents:71,731.00
Long Term Debt:$958.15K
Net Debt:$1.23M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $6.30M
Linear Growth: -6.6%
📊 Click to view full ECIA Revenue analysis & methodology →
Cost Of Revenue Ttm:$2.98M

Profitability Breakdown (2)

Gross profit TTM: $3.32M
Linear Growth: -6.5%
📊 Click to view full ECIA Gross Profit analysis & methodology →
-$319.68K

Bottom Line Performance (3)

-$380.94K
Income Before Tax:-$380.94K
Ebitda Ttm:-232,238.00

Operating Expenses (5)

Operating Expenses:3,635,609.00
R And D Expense:665,289.00
Sga Expense:1,362,140.00
Income Tax Expense:$0.00
Interest Expense:56,149.00

Expense Ratios (3)

R And D To Revenue Percentage:43.5%
Sga To Revenue Percentage:89.1%
Ebitda Margin:-3.7%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$4.06M
Current Assets:$2.45M
Ppe Net:250,016.00
Goodwill:0.00
Intangible Assets:$161.43K

Liability Structure (4)

Total Liabilities:2,191,972.00
Current Liabilities:1,071,571.00
Long Term Debt:$958.15K
Short Term Debt:$343.17K

Equity & Capital (3)

Equity:$1.86M
Retained Earnings:-$23.07M
Common Stock:24,938,998.00

Working Capital Items (3)

Accounts Receivable:761,947.00
Inventory:1,468,863.00
Accounts Payable:314,815.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:10,532.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: -$287.98K
Linear Growth: -17.5%
Free cash flow TTM: -$334.79K
Linear Growth: -18.9%
📊 Click to view full ECIA Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:-$6.69K
Capital Expenditures Ttm:46,806.00

Financing Activities (3)

Financing Cash Flow:-$87.32K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:255,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:87,438.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.03
-$0.03
Earnings Per Share Ttm:-$0.03

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.44
Operating Cash Flow Per Share:-$0.00

Book Value & Capital (2)

Book Value Per Share:$0.13
Cash Per Share:0.01

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.60x
Working Capital Turnover Ttm:4.58x

Receivables Management (2)

Receivables Turnover Ttm:8.27x
Days Sales Outstanding Ttm:44.15

Inventory Management (2)

Inventory Turnover Ttm:2.03x
Days Inventory Outstanding Ttm:179.68

Payables & Cash Cycle (2)

Days Payable Outstanding:38.51
Cash Conversion Cycle:185.32
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:80.00
Quality Score:35.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$339.97K
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-6.6%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):-18.9%
Operating Cash Flow Growth Rate (Linear):-17.5%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):-6.5%
Book Value Growth Rate (Linear):-15.7%
C. Company Profile & Context

Corporate Information (6)

Symbol:ECIA
Company Name:ENCISION, INC.
Sector:Healthcare
Industry:Medical Devices
Exchange:Over The Counter
Country:Unknown

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:14.19M
Shares Outstanding Basic:14.19M
Shares Outstanding Diluted:14.19M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-06-08 10:58:55 UTC
Data Timestamp:2026-06-08T10:58:55.692278
Scroll to Top